Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuxia Ye

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
ISA Transactions|January 7, 2019
Dynamic output feedback H<sub>∞</sub> control for 2D fuzzy systemsLizhen Li, Xiaofeng Li, Shuxia Ye
ISA Transactions|January 14, 2014
Robust H(∞) control for a class of 2-D discrete delayed systemsShuxia Ye, Jianzhen Li, Juan Yao
Sensors (Basel, Switzerland)|January 28, 2026
A PI-Dual-STGCN Fault Diagnosis Model Based on the SHAP-LLM Joint Explanation FrameworkZheng Zhao, Shuxia Ye, Liang Qi, et al.
Investigational New Drugs|January 10, 2012
Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer modelsDavid A Proia, Jim Sang, Suqin He, et al.
Molecular Cancer Therapeutics|December 7, 2011
Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapyWeiwen Ying, Zhenjian Du, Lijun Sun, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
ISA Transactions|January 7, 2019
Dynamic output feedback H<sub>∞</sub> control for 2D fuzzy systemsLizhen Li, Xiaofeng Li, Shuxia Ye
ISA Transactions|January 14, 2014
Robust H(∞) control for a class of 2-D discrete delayed systemsShuxia Ye, Jianzhen Li, Juan Yao
Sensors (Basel, Switzerland)|January 28, 2026
A PI-Dual-STGCN Fault Diagnosis Model Based on the SHAP-LLM Joint Explanation FrameworkZheng Zhao, Shuxia Ye, Liang Qi, et al.
Investigational New Drugs|January 10, 2012
Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer modelsDavid A Proia, Jim Sang, Suqin He, et al.
Molecular Cancer Therapeutics|December 7, 2011
Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapyWeiwen Ying, Zhenjian Du, Lijun Sun, et al.
Pageof 1